Full Text View
Tabular View
No Study Results Posted
Related Studies
A Trial of Ligation Plus Nadolol Versus Nadolol Alone in the Prophylaxis of First Variceal Bleeding in Cirrhosis
This study has been completed.
Study NCT00921349   Information provided by National Science Council, Taiwan

First Received on June 3, 2009.   Last Updated on June 15, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Variceal Bleeding
Cirrhosis
Additional conditions recognized in this trial
Fibrosis
Hemorrhage
Liver Cirrhosis
More general conditions related to this trial
Digestive System Diseases
Liver Diseases
Pathologic Processes
Interventions listed in this trial
Ligation of varices
Nadolol
Additional drug interventions recognized in this trial
Adrenergic beta-Antagonists
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Antagonists
Anti-Arrhythmia Agents
Antihypertensive Agents
Autonomic Agents
Cardiovascular Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sympatholytics
Therapeutic Uses
Sponsors listed in this trial
National Science Council, Taiwan


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services